Tandem Diabetes Care (TNDM) Other Accumulated Expenses (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Other Accumulated Expenses came in at $84.1 million in Q1 2026, down 8.4% YoY from $91.8 million in Q1 2025, and up 11.78% on a QoQ basis from $75.2 million in Q4 2025.
Tandem Diabetes Care (TNDM) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Other Accumulated Expenses data on file, last reported at $84.1 million in Q1 2026.
- Quarterly Other Accumulated Expenses fell 8.4% year-over-year to $84.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.1 million (down 8.4% YoY) and the FY2025 annual result came in at $75.2 million, up 52.57% from the prior year.
- Other Accumulated Expenses climbed to $84.1 million in Q1 2026, from $75.2 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $100.0 million in Q2 2025 to a low of $22.9 million in Q1 2022.
- A 5-year average of $48.7 million and a median of $33.9 million in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2025 — Other Accumulated Expenses jumped 202.63% — and 2026, when it declined 8.4%.
- Tracing TNDM's Other Accumulated Expenses over 5 years: stood at $29.3 million in 2022, then slipped by 2.94% to $28.5 million in 2023, then surged by 73.26% to $49.3 million in 2024, then surged by 52.57% to $75.2 million in 2025, then rose by 11.78% to $84.1 million in 2026.
- The last three Other Accumulated Expenses figures came in at $84.1 million (Q1 2026), $75.2 million (Q4 2025), and $96.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.56 Bn | 1.10 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 81.38 Mn |
| Mar 31, 2026 | 84.10 Mn |
| Dec 31, 2025 | 75.24 Mn |
| Sep 30, 2025 | 96.88 Mn |
| Jun 30, 2025 | 99.99 Mn |
| Mar 31, 2025 | 91.81 Mn |
| Dec 31, 2024 | 49.31 Mn |
| Sep 30, 2024 | 38.32 Mn |
| Jun 30, 2024 | 34.21 Mn |
| Mar 31, 2024 | 30.34 Mn |
| Dec 31, 2023 | 28.46 Mn |
| Sep 30, 2023 | 33.93 Mn |
| Jun 30, 2023 | 27.82 Mn |
| Mar 31, 2023 | 30.14 Mn |
| Dec 31, 2022 | 29.33 Mn |
| Sep 30, 2022 | 31.14 Mn |
| Jun 30, 2022 | 23.92 Mn |
| Mar 31, 2022 | 22.89 Mn |
| Dec 31, 2021 | 23.39 Mn |
| Sep 30, 2021 | 20.73 Mn |